Fertility Clock Headlines, Fertility Headlines

Breakthrough for IVF? Selecting the Most Promising Embryos

Embryo4A recent study in Reproductive BioMedicine Online on 5-day old human blastocysts shows that those with an abnormal chromosomal composition can be identified by the rate at which they have developed to blastocysts, thereby classifying the risk of genetic abnormality without a biopsy. In a new study the same group has undertaken a retrospective study, using their predictive model to assess the likelihood of any embryo transferred resulting in a successful pregnancy, with very encouraging outcomes.

One of the greatest challenges in assisted reproduction is to find the one embryo, which can develop successfully. Now, combining time lapse imaging of IVF embryos cultured for 5 days to the blastocyst stage with trophoblast biopsy, it has proved possible to correlate the rate of blastocyst formation with chromosomal abnormalities. Such an approach should allow early and widely accessible non-invasive identification of the best embryo to place in the uterus. Read full article…

Fertility Clock Headlines, Fertility Headlines

Making Babies: Selling Embryos, Despite Ethical Concerns, Addresses Genuine Needs

The latest round of ethical contretemps is an intriguing April article in The New England Journal of Medicine, “Made-to-Order Embryos for Sale—A Brave New World?” which discusses—comprehensively and dispassionately—many of the concerns raised about embryo donations, whether gifted or for sale.

Fertility Clock Headlines, Fertility Headlines

Powder Women’s Eggs for Home Storage

Just add water and sperm – any romance should be provided separately. In future, women who want to safeguard their fertility may be able to store their eggs at home as a powder. To revive them for an attempt at having a baby, all they would need to do is empty the sachet, add water, fertilize with sperm and implant the embryo.

Fertility Clock Headlines, Fertility Headlines

Embryo-like stem cells enter first human trial

EmbryoDevelopment

It will be the first clinical study to put induced pluripotent stem (iPS) cells into humans — and where more fitting than in Japan, where Shinya Yamanaka garnered a Nobel prize last December for showing how to take bodily cells and return them to an embryo-like pluripotent state.

Masayo Takahashi of the Center for Developmental Biology in Kobe just cleared the second and, observers say, most difficult hurdle in starting her iPS cell trial to treat age-related macular degeneration, a condition that affects the retina and can lead to blindness.

On Wednesday an institutional review board (IRB) at the Institute for Biomedical Research and Innovation(IBRI), which is going to sponsor the trial, gave conditional approval. The team needs now only to notify the IRB of the final results of some preclinical safety trials now underway (see story in Japanese). Read full article.

Fertility Clock Headlines, Fertility Headlines

Clinics to Begin Tests for Genetic Disorders in Embryos

COUPLES who want to find out if they are going to have a baby with an inherited disorder can now avail of controversial tests in Irish clinics for the first time.

Embryos produced through IVF can now be tested to show if they are free of specific disorders, such as cystic fibrosis. It means the couple can choose not to have an embryo which proves positive for the disorder implanted in the mother’s womb.

Couples previously had to go abroad for the tests, but licences have been granted to the Beacon CARE Fertility Clinic in Dublin and the Cork Fertility Clinic. Read full article.

Fertility Clock Headlines, Fertility Headlines

Comprehensive Chromosomal Analysis Shown to Improve IVF Outcomes

Researchers at the 68th Annual Meeting of the American Society for Reproductive Medicine presented research showing that by screening all the chromosomes in an embryo the number of successful pregnancies could be increased over traditional methods of Assisted Reproductive Technologies (ART).